[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:klippel-trenaunay-syndrome":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":21,"states":22},"Klippel Trenaunay syndrome",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06789913","A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)",[11],"Phase 2","RECRUITING","2026-08-26T02:17:21.315591Z","2026-07-05T05:32:16.695791Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT03001180","Identification of Biomarkers for Patients with Vascular Anomalies",[],"2026-08-26T02:17:57.117858Z","2026-05-13T02:55:06.106471Z",[],[]]